Agilon Health Inc. (AGL) Misses Q4 EPS by 4c ; Offers Guidance

Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.51 billion.

GUIDANCE:

Agilon Health Inc. sees Q1 2025 revenue of $1.48-1.52 billion, versus the consensus of $1.69 billion.

Agilon Health Inc. sees FY2025 revenue of $5.82-6.02 billion, versus the consensus of $6.61 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Boeing wins $2 billion satellite contract from DoW
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook